NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email Many companies are cancelling employee work trips because of turmoil from U.S. trade and immigration policies, even as airlines bet big on business class revenue.Read More